SUPREME-HN: a retrospective biomarker study assessing the prognostic value of PD-L1 expression in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Saved in:
| Title: | SUPREME-HN: a retrospective biomarker study assessing the prognostic value of PD-L1 expression in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. |
|---|---|
| Authors: | Pai SI; Massachusetts General Hospital Cancer Center, Harvard Medical School, 55 Fruit Street, GRJ 9-904G, Boston, MA, 02114, USA. sara.pai@mgh.harvard.edu., Cohen EEW; UC San Diego Health System, Moores Cancer Center, La Jolla, CA, USA., Lin D; Massachusetts General Hospital Cancer Center, Harvard Medical School, 55 Fruit Street, GRJ 9-904G, Boston, MA, 02114, USA.; Massachusetts Eye and Ear, Boston, MA, USA., Fountzilas G; Aristotle University of Thessaloniki, Thessaloniki, Greece., Kim ES; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Mehlhorn H; Universitaetsklinikum Leipzig, Klinik und Poliklinik fur HNO-Heilkunde, Leipzig, Germany., Baste N; Department of Oncology, Hospital Universitari Vall d'Hebron & Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain., Clayburgh D; Oregon Health & Science University, Portland, OR, USA., Lipworth L; Vanderbilt University Medical Center, Nashville, TN, USA., Resteghini C; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Shara N; MedStar Health Research Institute, Hyattsville, MD, USA., Fujii T; Osaka International Cancer Institute, Osaka, Japan., Zhang J; Baylor College of Medicine, Houston, TX, USA., Stokes M; Evidera, Lexington, MA, USA., Wang H; AstraZeneca, Gaithersburg, MD, USA., Twumasi-Ankrah P; AstraZeneca, Gaithersburg, MD, USA., Wildsmith S; AstraZeneca, Cambridge, UK., Khaliq A; AstraZeneca, Gaithersburg, MD, USA., Melillo G; AstraZeneca, Gaithersburg, MD, USA., Shire N; AstraZeneca, Gaithersburg, MD, USA. |
| Source: | Journal of translational medicine [J Transl Med] 2019 Dec 26; Vol. 17 (1), pp. 429. Date of Electronic Publication: 2019 Dec 26. |
| Publication Type: | Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31878938 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: SUPREME-HN: a retrospective biomarker study assessing the prognostic value of PD-L1 expression in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Pai+SI%22">Pai SI</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, 55 Fruit Street, GRJ 9-904G, Boston, MA, 02114, USA. sara.pai@mgh.harvard.edu.<br /><searchLink fieldCode="AU" term="%22Cohen+EEW%22">Cohen EEW</searchLink>; UC San Diego Health System, Moores Cancer Center, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lin+D%22">Lin D</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, 55 Fruit Street, GRJ 9-904G, Boston, MA, 02114, USA.; Massachusetts Eye and Ear, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Fountzilas+G%22">Fountzilas G</searchLink>; Aristotle University of Thessaloniki, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Kim+ES%22">Kim ES</searchLink>; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.<br /><searchLink fieldCode="AU" term="%22Mehlhorn+H%22">Mehlhorn H</searchLink>; Universitaetsklinikum Leipzig, Klinik und Poliklinik fur HNO-Heilkunde, Leipzig, Germany.<br /><searchLink fieldCode="AU" term="%22Baste+N%22">Baste N</searchLink>; Department of Oncology, Hospital Universitari Vall d'Hebron & Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Clayburgh+D%22">Clayburgh D</searchLink>; Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Lipworth+L%22">Lipworth L</searchLink>; Vanderbilt University Medical Center, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Resteghini+C%22">Resteghini C</searchLink>; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Shara+N%22">Shara N</searchLink>; MedStar Health Research Institute, Hyattsville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Fujii+T%22">Fujii T</searchLink>; Osaka International Cancer Institute, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Zhang+J%22">Zhang J</searchLink>; Baylor College of Medicine, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Stokes+M%22">Stokes M</searchLink>; Evidera, Lexington, MA, USA.<br /><searchLink fieldCode="AU" term="%22Wang+H%22">Wang H</searchLink>; AstraZeneca, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Twumasi-Ankrah+P%22">Twumasi-Ankrah P</searchLink>; AstraZeneca, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Wildsmith+S%22">Wildsmith S</searchLink>; AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Khaliq+A%22">Khaliq A</searchLink>; AstraZeneca, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Melillo+G%22">Melillo G</searchLink>; AstraZeneca, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Shire+N%22">Shire N</searchLink>; AstraZeneca, Gaithersburg, MD, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101190741%22">Journal of translational medicine</searchLink> [J Transl Med] 2019 Dec 26; Vol. 17 (1), pp. 429. <i>Date of Electronic Publication: </i>2019 Dec 26. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101190741 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1479-5876 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214795876%22">14795876 </searchLink><i>NLM ISO Abbreviation: </i>J Transl Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31878938 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12967-019-02182-1 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 429 Titles: – TitleFull: SUPREME-HN: a retrospective biomarker study assessing the prognostic value of PD-L1 expression in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Pai SI – PersonEntity: Name: NameFull: Cohen EEW – PersonEntity: Name: NameFull: Lin D – PersonEntity: Name: NameFull: Fountzilas G – PersonEntity: Name: NameFull: Kim ES – PersonEntity: Name: NameFull: Mehlhorn H – PersonEntity: Name: NameFull: Baste N – PersonEntity: Name: NameFull: Clayburgh D – PersonEntity: Name: NameFull: Lipworth L – PersonEntity: Name: NameFull: Resteghini C – PersonEntity: Name: NameFull: Shara N – PersonEntity: Name: NameFull: Fujii T – PersonEntity: Name: NameFull: Zhang J – PersonEntity: Name: NameFull: Stokes M – PersonEntity: Name: NameFull: Wang H – PersonEntity: Name: NameFull: Twumasi-Ankrah P – PersonEntity: Name: NameFull: Wildsmith S – PersonEntity: Name: NameFull: Khaliq A – PersonEntity: Name: NameFull: Melillo G – PersonEntity: Name: NameFull: Shire N IsPartOfRelationships: – BibEntity: Dates: – D: 26 M: 12 Text: 2019 Dec 26 Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 1479-5876 Numbering: – Type: volume Value: 17 – Type: issue Value: 1 Titles: – TitleFull: Journal of translational medicine Type: main |
| ResultId | 1 |